
BeiGene, Ltd.
USD184.71
+0.90 (+0.49%)
CEO
John V. Oyler
IPO Date
2016-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$184.00
Prev. Close
$183.81
Day Low
$183.91
Day High
$187.42
52W Low
$126.97
52W High
$248.16
Market Cap
$20.21B
Volume
0.33M
BeiGene Announces Acceptance by Swissmedic of Marketing Authorization Application for BRUKINSA® (Zanubrutinib) in Waldenström's Macroglobulinaemia